An instant classic core IM. As someone who always viewed the watchman as a magical device, this put a lot into perspective for me. open.spotify.com/episode/17ip...

#222 AFib Stroke Prevention: WATCHMAN, DOACs, and the CHAMPION-AF Trial | Beyond Journal Club Segment with NEJM Group

Core IM | Internal Medicine Podcast · Episode

open.spotify.com

With just a 12 minute video, advanced care planning documentation increased by 16%, with 50% in intervention group opting for conservative care vs 30% in controls. We need to be discussing conservative care options more with our older patients! jamanetwork.com/journals/jam...

Really liked this breakdown of the STAREE trial. open.spotify.com/episode/3waO...

STAREE Trial : Statins after Seventy?

Heartline: The Cardio Trials Podcast · Episode

open.spotify.com

Wild to think that 5 years ago everyone told me not to do nephrology because “there are no new treatments for kidney disease” and now here I am a brand new July nephrology fellow filling out my first form requesting approval for Sibeprenlimab for IgA Nephropathy in GN clinic today!

Spent last night at the montefiore research symposium discussing some palliative nephrology!

Listen to this special #NephMadness episode of @coreimpodcast.bsky.social to hear @shreyatrivedimd.bsky.social, @noahmarkewitz11.bsky.social , and @jrkott27.bsky.social discuss all things POCUS: www.coreimpodcast.com/2026/03/23/p...

A fantastic discussion on what it really means to tell a patient they have high risk APOL1 alleles, and if we are benefiting them by doing so. open.spotify.com/episode/1HBJ...

Reharing my #shiny leaf plot app, demonstrating the relationship between prevalence/pre-test probability, sensitivity, specificity and post-test probabilities. lmsaxhaug.shinyapps.io/Leaf_App/ #rstats #meded #emimcc #cardiosky #medsky

1/ 🚨 NEW episode on venous congestion & the VExUS score 💧 Venous congestion is a century-old concept, but modern tools now allow clinicians to detect, quantify, and monitor it ‼️ 🖥️: www.coreimpodcast.com/2025/11/19/v...

The way to get younger doctors back to the bedside is with data the physical exam finding outperforms other care. This is exactly what the ANDROMEDA shock 1 and 2 trial has done for capillary refill time. This is also the reason POCUS has brought younger docs back to the bedside!

NEJM.org@nejm.org · 12mo ago

The authors of a new review provide practical suggestions for clinical educators to reinvigorate the teaching and practice of bedside clinical skills in the modern health care environment. Learn more: nej.md/4nUirnP #MedSky #MedEd

A positive trial in cardiac prevention for HD patients, how cool is this!

NEJM.org@nejm.org · 12mo ago

In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo @asnkidney.bsky.social | #KidneyWk

Such a cool study and further evidence on the funny and sad truth that hemodynamic shifts of dialysis actually worsen renal recovery jamanetwork.com/journals/jam...

A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury

This trial examines whether a conservative dialysis strategy can improve recovery of kidney function for patients with acute kidney injury who require dialysis.

jamanetwork.com

Love a well made sequel! But 10 percent absolute mortality decrease might have been asking for too much? Also why bicarb vs. no bicarb and not bicarb vs placebo? Have to wonder if no bicarb group received dialysis early because everyone knew they weren’t getting bicarb.

JAMA@jama.com · last yr.

📢 Presented today in the #LIVES2025 Hot Topics session: Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: The BICARICU-2 Randomized Clinical Trial, from JAMA_current. ➡️ Free to read online: ja.ma/4hRZXmF

Had so much to say about HRS we had to split it into two episodes! Check out part 2 on HRS treatment, Transplant, and a topic near and dear to my heart, palliative care.

CORE IM@coreimpodcast.bsky.social · last yr.

1/ 🚨 NEW #5Pearls: Hepatorenal Syndrome Part ✌️ Let’s dive into treatment 🌊! 1️⃣ Vasoconstrictors 2️⃣ Albumin 3️⃣ Diuretics Goal: raise MAP by 10-15 ‼️ 🖥️: www.coreimpodcast.com/2025/10/22/h...

🆕🔥🔥CloCeBa RCT Cloxacillin versus cefazolin for MSSA Bacteraemia Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky www.thelancet.com/journals/lan...

It has been a dream to be able to be a part of my favorite podcast. Check out this very fun episode on one of the most interesting diseases, Hepatorenal Syndrome!

CORE IM@coreimpodcast.bsky.social · last yr.

1/ 🚨 NEW #5Pearls: Hepatorenal Syndrome (HRS) part 1️⃣ AKI + portal HTN 🟰hepatorenal syndrome 🖥️: www.coreimpodcast.com/2025/10/15/h...

Excited to share a new case report from my time in the CCU… we present a multidisciplinary management of a RCA STEMI complicated by cardiogenic shock, severe mitral regurgitation, and complete heart block. www.jacc.org/doi/abs/10.1...

Multidisciplinary Management and Hemodynamic Rescue of Cardiogenic Shock in RCA STEMI With Severe Mitral Regurgitation:

jacc.org

“Nothing is so privileged as thinking history belongs to the past.”- John Green. Everything is Tuberculosis

Found a nephrology textbook from 1859 at a bookstore. Even back then nephrologists loved saying there’s no such thing as normal urine labs, only normal serum labs.

Love this change in the new 2025 AHA HTN guidelines. Hypertensive urgency completely removed. Asymptomatic severe HTN as outpatient , DO NOT send to the emergency room, and more importantly if in the ED, NOT to give IV meds, nor admit. Much needed evidence based change.